3 Potential Stock-Moving Drug Events In The Second Half Of 2016
July 01, 2016 at 07:15 AM EDT
Some major clinical-trial news is expected from Eli Lilly, Gilead, Regeneron and Sanofi.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.